144 related articles for article (PubMed ID: 19373451)
21. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
22. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
23. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
[TBL] [Abstract][Full Text] [Related]
24. Activation-induced deaminase-coupled DNA demethylation is not crucial for the generation of induced pluripotent stem cells.
Habib O; Habib G; Do JT; Moon SH; Chung HM
Stem Cells Dev; 2014 Feb; 23(3):209-18. PubMed ID: 24083501
[TBL] [Abstract][Full Text] [Related]
25. Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells.
Dai Y; Guo Y; Wang C; Liu Q; Yang Y; Li S; Guo X; Lian R; Yu R; Liu H; Chen J
PLoS One; 2014; 9(10):e109856. PubMed ID: 25333522
[TBL] [Abstract][Full Text] [Related]
26. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
27. Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system.
Lee M; Choi NY; Park S; Bang JS; Lee Y; Jeong D; Ham S; Lim S; Kim KH; Ko K
Stem Cell Res; 2020 Oct; 48():101943. PubMed ID: 32777770
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane.
Kita K; Gauglitz GG; Phan TT; Herndon DN; Jeschke MG
Stem Cells Dev; 2010 Apr; 19(4):491-502. PubMed ID: 19635009
[TBL] [Abstract][Full Text] [Related]
29. Nanog-independent reprogramming to iPSCs with canonical factors.
Carter AC; Davis-Dusenbery BN; Koszka K; Ichida JK; Eggan K
Stem Cell Reports; 2014 Feb; 2(2):119-26. PubMed ID: 24527385
[TBL] [Abstract][Full Text] [Related]
30. Prolonged proteasome inhibition cyclically upregulates Oct3/4 and Nanog gene expression, but reduces induced pluripotent stem cell colony formation.
Floyd ZE; Staszkiewicz J; Power RA; Kilroy G; Kirk-Ballard H; Barnes CW; Strickler KL; Rim JS; Harkins LL; Gao R; Kim J; Eilertsen KJ
Cell Reprogram; 2015 Apr; 17(2):95-105. PubMed ID: 25826722
[TBL] [Abstract][Full Text] [Related]
31. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
32. Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.
Munro MJ; Peng L; Wickremesekera SK; Tan ST
PLoS One; 2020; 15(5):e0232934. PubMed ID: 32428045
[TBL] [Abstract][Full Text] [Related]
33. Early reprogramming regulators identified by prospective isolation and mass cytometry.
Lujan E; Zunder ER; Ng YH; Goronzy IN; Nolan GP; Wernig M
Nature; 2015 May; 521(7552):352-6. PubMed ID: 25830878
[TBL] [Abstract][Full Text] [Related]
34. Induced pluripotent stem cells as a model for diabetes investigation.
Stepniewski J; Kachamakova-Trojanowska N; Ogrocki D; Szopa M; Matlok M; Beilharz M; Dyduch G; Malecki MT; Jozkowicz A; Dulak J
Sci Rep; 2015 Feb; 5():8597. PubMed ID: 25716801
[TBL] [Abstract][Full Text] [Related]
35. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
36. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
37. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
38. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
Cai Y; Dai X; Zhang Q; Dai Z
Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
[TBL] [Abstract][Full Text] [Related]
39. Reprogramming adult hematopoietic cells.
Kaneko S; Otsu M; Nakauchi H
Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
[TBL] [Abstract][Full Text] [Related]
40. NANOG priming before full reprogramming may generate germ cell tumours.
Grad I; Hibaoui Y; Jaconi M; Chicha L; Bergström-Tengzelius R; Sailani MR; Pelte MF; Dahoun S; Mitsiadis TA; Töhönen V; Bouillaguet S; Antonarakis SE; Kere J; Zucchelli M; Hovatta O; Feki A
Eur Cell Mater; 2011 Nov; 22():258-74; discussio 274. PubMed ID: 22071697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
